Early Positive Fluid Balance is Associated with Mortality in Patients Treated with Veno-Arterial Extra Corporeal Membrane Oxygenation For Cardiogenic Shock: a Retrospective Cohort Study
Overview
Authors
Affiliations
Purpose: Veno-arterial Extracoporeal Membrane Oxygenation (VA-ECMO) provides circulatory assistance for patients in cardiogenic shock. Large quantities of fluids are often required, especially during the early stages, but can result in a potentially harmful fluid-overload. The objective was to determine the association of early fluid-balance and mortality.
Methods: Retrospective single-center study in 101 VA-ECMO patients between 2013 and 2016. Daily fluid-balance and weight changes over the 5 first days were observed. Analyses between survivors and non-survivors were conducted using Mann-Whitney tests and logistic regression multivariable and Cox hazard-proportional analyses to determine any association with 28-days mortality.
Results: Mortality was 47.5%. The fluid-balance was higher in non-survivors at day-1 (47.3[18.1-71.9] vs. 19.3[1.5-36.2] mL/kg, P < 0.0001) and day-2 (30.6[14.8-71.0] vs. 10.1[-9.8 to 34.7] mL/kg, P = 0.025), as was the cumulative fluid-balance over the first 5 days (107.3[40.5-146.2] vs. 53.0[7.5-74.3] mL/kg, P = 0.04). The administration of unintentional fluids (used for preparation and infusion of drugs) represented an important part of the administrated fluids (15 mL/kg/d-23 mL/kg/d). A significant but moderate correlation was observed between fluid-balance and weight variations over the 5 days (r values ranging from 0.36 to 0.54). Among other parameters, day-1 fluid-balance was independently associated with mortality (OR = 14.34 [1.58-129.79], P = 0.02) and day-1 and day-2 with time to death (HR = 8.26 [1.12-60.98], P = 0.04 and 2.89 [1.26-6.65], P = 0.01). A threshold of 38.8 mL/kg predicted mortality with a sensitivity of 60% and specificity of 83% (area under the curve: 0.749).
Conclusion: Early positive fluid-balance is associated with mortality in VA-ECMO patients.
Taira T, Inoue A, Okamoto H, Maekawa K, Hifumi T, Sakamoto T Clin Res Cardiol. 2024; .
PMID: 38635032 DOI: 10.1007/s00392-024-02444-z.
Dong Y, Mao L, Zhang Z, Li X, Li W, Gao Y Am J Transl Res. 2023; 15(11):6597-6604.
PMID: 38074831 PMC: 10703662.
Waskowski J, Michel M, Steffen R, Messmer A, Pfortmueller C Front Med (Lausanne). 2022; 9:1040055.
PMID: 36465945 PMC: 9712448. DOI: 10.3389/fmed.2022.1040055.
Raasveld S, Volleman C, Combes A, Broman L, Taccone F, Peters E Intensive Care Med Exp. 2022; 10(1):50.
PMID: 36424482 PMC: 9691798. DOI: 10.1186/s40635-022-00478-z.
Wang X, Wang H, Du X, Wang Z, Li C, Anderson C Trials. 2022; 23(1):684.
PMID: 35986410 PMC: 9389730. DOI: 10.1186/s13063-022-06617-x.